Elizabeth Garner

1.7k total citations
13 papers, 606 citations indexed

About

Elizabeth Garner is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Elizabeth Garner has authored 13 papers receiving a total of 606 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 8 papers in Oncology and 5 papers in Immunology. Recurrent topics in Elizabeth Garner's work include CRISPR and Genetic Engineering (6 papers), DNA Repair Mechanisms (6 papers) and CAR-T cell therapy research (5 papers). Elizabeth Garner is often cited by papers focused on CRISPR and Genetic Engineering (6 papers), DNA Repair Mechanisms (6 papers) and CAR-T cell therapy research (5 papers). Elizabeth Garner collaborates with scholars based in United States, Switzerland and United Kingdom. Elizabeth Garner's co-authors include Agata Smogorzewska, Vincenzo Costanzo, Kenneth Raj, Alessia Balestrini, Molly C. Kottemann, Yonghwan Kim, Francis P. Lach, Ali Jazayeri, James E. Haber and Alessia Errico and has published in prestigious journals such as Journal of Clinical Oncology, The EMBO Journal and Blood.

In The Last Decade

Elizabeth Garner

13 papers receiving 602 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elizabeth Garner United States 11 531 195 97 91 89 13 606
Demis Menolfi United States 12 496 0.9× 147 0.8× 64 0.7× 97 1.1× 72 0.8× 16 545
Peter Burkovics Hungary 12 663 1.2× 187 1.0× 48 0.5× 88 1.0× 133 1.5× 16 701
Raquel Cuella-Martin United States 7 600 1.1× 203 1.0× 103 1.1× 58 0.6× 48 0.5× 10 635
Timsi Rao United States 10 517 1.0× 167 0.9× 72 0.7× 36 0.4× 69 0.8× 12 595
Lindsey R. Pack United States 13 427 0.8× 143 0.7× 44 0.5× 106 1.2× 73 0.8× 14 590
Joonyoung Her United States 9 446 0.8× 193 1.0× 48 0.5× 39 0.4× 55 0.6× 11 493
Shanaya Shital Shah United States 6 568 1.1× 173 0.9× 52 0.5× 33 0.4× 76 0.9× 6 634
Samantha Ciccone United States 13 493 0.9× 73 0.4× 106 1.1× 88 1.0× 98 1.1× 13 573
Shane McDevitt United States 6 515 1.0× 193 1.0× 60 0.6× 30 0.3× 53 0.6× 6 579
Sneha Saxena India 11 532 1.0× 223 1.1× 42 0.4× 46 0.5× 69 0.8× 13 617

Countries citing papers authored by Elizabeth Garner

Since Specialization
Citations

This map shows the geographic impact of Elizabeth Garner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth Garner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth Garner more than expected).

Fields of papers citing papers by Elizabeth Garner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elizabeth Garner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth Garner. The network helps show where Elizabeth Garner may publish in the future.

Co-authorship network of co-authors of Elizabeth Garner

This figure shows the co-authorship network connecting the top 25 collaborators of Elizabeth Garner. A scholar is included among the top collaborators of Elizabeth Garner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elizabeth Garner. Elizabeth Garner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Daver, Naval, Abhishek Maiti, David A. Sallman, et al.. (2024). A first-in-human phase 1, multicenter, open-label study of CB-012, a next-generation CRISPR-edited allogeneic anti-CLL-1 CAR-T cell therapy for adults with relapsed/refractory acute myeloid leukemia (AMpLify).. Journal of Clinical Oncology. 42(16_suppl). TPS6586–TPS6586. 5 indexed citations
2.
3.
Garner, Elizabeth, Paul D. Donohoue, Mara Bryan, et al.. (2022). Abstract LB009: A BCMA-specific allogeneic CAR-T cell therapy (CB-011) genome-engineered to express an HLA-E fusion transgene to prevent immune cell rejection. Cancer Research. 82(12_Supplement). LB009–LB009. 1 indexed citations
4.
5.
6.
Ouyang, Jian, Elizabeth Garner, Hai Dang Nguyen, et al.. (2014). Noncovalent Interactions with SUMO and Ubiquitin Orchestrate Distinct Functions of the SLX4 Complex in Genome Maintenance. Molecular Cell. 57(1). 108–122. 67 indexed citations
7.
Garner, Elizabeth, Yonghwan Kim, Francis P. Lach, Molly C. Kottemann, & Agata Smogorzewska. (2013). Human GEN1 and the SLX4-Associated Nucleases MUS81 and SLX1 Are Essential for the Resolution of Replication-Induced Holliday Junctions. Cell Reports. 5(1). 207–215. 113 indexed citations
8.
Garner, Elizabeth & Agata Smogorzewska. (2011). Ubiquitylation and the Fanconi anemia pathway. FEBS Letters. 585(18). 2853–2860. 49 indexed citations
9.
Balestrini, Alessia, Claudia Cosentino, Alessia Errico, Elizabeth Garner, & Vincenzo Costanzo. (2010). GEMC1 is a TopBP1-interacting protein required for chromosomal DNA replication. Nature Cell Biology. 12(5). 484–491. 81 indexed citations
10.
Garner, Elizabeth & Vincenzo Costanzo. (2009). Studying the DNA damage response using in vitro model systems. DNA repair. 8(9). 1025–1037. 35 indexed citations
11.
Garner, Elizabeth & Kenneth Raj. (2008). Protective mechanisms of p53-p21-pRb proteins against DNA damage-induced cell death. Cell Cycle. 7(3). 277–282. 94 indexed citations
12.
Jazayeri, Ali, Alessia Balestrini, Elizabeth Garner, James E. Haber, & Vincenzo Costanzo. (2008). Mre11–Rad50–Nbs1-dependent processing of DNA breaks generates oligonucleotides that stimulate ATM activity. The EMBO Journal. 27(14). 1953–1962. 103 indexed citations
13.
Garner, Elizabeth, Fabio Martinon, Jürg Tschopp, Peter Beard, & Kenneth Raj. (2007). Cells with Defective p53-p21-pRb Pathway Are Susceptible to Apoptosis Induced by p84N5 via Caspase-6. Cancer Research. 67(16). 7631–7637. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Demis Menolfi Breakdown of academic impact, for papers by Peter Burkovics Breakdown of academic impact, for papers by Raquel Cuella-Martin Breakdown of academic impact, for papers by Timsi Rao Breakdown of academic impact, for papers by Lindsey R. Pack Breakdown of academic impact, for papers by Joonyoung Her Breakdown of academic impact, for papers by Shanaya Shital Shah Breakdown of academic impact, for papers by Samantha Ciccone Breakdown of academic impact, for papers by Shane McDevitt Breakdown of academic impact, for papers by Sneha Saxena
Rankless by CCL
2026